Telmisartan and cardioprotection - Wikidata - thesis-toulmin - TriplyDB

Telmisartan and cardioprotection

Telmisartan and cardioprotection

http://www.wikidata.org/entity/Q26861422

about

Hypertension management in the high cardiovascular risk population.Phase 4 Studies in Heart Failure - What is Done and What is Needed?

P2860

Q36634462-E53C5187-15B3-4B06-B800-7F87AD27E2B1 Q38859866-95495F99-D04C-4A7B-8148-7F15FBD82928

P2860

Telmisartan and cardioprotection

http://www.wikidata.org/entity/Q26861422

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Telmisartan and cardioprotection

@ast

Telmisartan and cardioprotection

@en

Telmisartan and cardioprotection

@nl

type

label

Telmisartan and cardioprotection

@ast

Telmisartan and cardioprotection

@en

Telmisartan and cardioprotection

@nl

prefLabel

Telmisartan and cardioprotection

@ast

Telmisartan and cardioprotection

@en

Telmisartan and cardioprotection

@nl

P1433

Q26861422-42CC6697-C378-491C-923D-13441FD612DF

P1476

Q26861422-62A43DBA-AAFB-4041-B051-1B9455F3BFAA

P2093

Q26861422-D7EFFA8A-03AE-4B95-BC43-0234E5A6D057

P2860

Q26861422-03D82D5A-EAB1-419C-8396-E1142A7C4E06

Q26861422-0600442B-3436-4EF3-BD4C-089A7661536C

Q26861422-0EFFB843-27AA-4B91-A6A7-B26112CD772C

Q26861422-104A47AF-31D1-4C07-8E5A-AD44BC7402CE

Q26861422-15A361E2-1930-440E-B7D9-32904451EF8A

Q26861422-1D1EEAE7-CB89-43B1-823D-A27DBB253332

Q26861422-202AA1B3-A907-41EC-B125-B3E2B572AE4C

Q26861422-24E24D53-B3DB-4FEB-AE59-335977921950

Q26861422-2575D2BD-7BE2-4E7E-8DAC-9AE119D8FBDC

Q26861422-3780338A-08F2-4F56-B82D-B4259B34314F

P304

Q26861422-BBCD78F6-1EF9-4733-95FC-39B657F98922

P31

Q26861422-80C627EF-9C52-4BEC-B557-488E88A52725

Q26861422-9F38B7AD-E30C-4F30-A23B-A4CEC29A1B8E

P356

Q26861422-6DA374E8-74C3-4B67-92EA-9E14A1C617EE

P407

Q26861422-942E0286-EEBD-4833-ACFE-1EA49CCA2FB2

P478

Q26861422-77850BB5-9BAF-4968-A50E-9EF1EEAF8157

P577

Q26861422-BEAA1FF9-FDDF-40C0-B6AE-22A1D8920032

Q26861422-FC93F587-F637-469D-99FA-D28BD3C11B38

P698

Q26861422-FD82FDF3-2D01-4017-9D10-6EBBA6A3740F

P921

Q26861422-28A036D7-5C1A-494E-B1E7-722E787DD5B7

Q26861422-436ED9BF-B6A2-4DA8-9856-867276066BC1

Q26861422-62613640-5271-40D5-AC13-244FA3C8AABD

Q26861422-653A5778-24CF-4EFB-B2A0-15AA616E9B9F

Q26861422-75B3FBD5-8AD1-4C6B-93AC-D2FFCA32BB70

Q26861422-82AC5B9E-C6B7-4218-AB97-FB2FE319BE83

P932

Q26861422-0D9C10C4-970D-47C5-8935-625A18B1E57F

P356

P1433

Vascular Health and Risk Management

P1476

Telmisartan and cardioprotection

@en

P2093

Samy McFarlane

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Effect of valsartan on the incidence of diabetes and cardiovascular events

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

Effect of ramipril on the incidence of diabetes.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Telmisartan to prevent recurrent stroke and cardiovascular events.

P304

677-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S9447

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2011-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22140319

http://www.w3.org/2001/XMLSchema#string

P921

carboxylic acid

heterocyclic compound

mechanism of action

cardiovascular disease

P932

3225351

http://www.w3.org/2001/XMLSchema#string